Case #1: Treating a Patient with EGFR Exon 19 Lung Cancer- 2024 Case-Based Panel Discussions

Case Based Panel Discussion - EGFR - Chemotherapy and EGFR Inhibitor Concurrently or Sequentially?Подробнее

Case #3: Patient with EGFR Exon 21 L858R Alteration NSCLC- 2024 Case Based Panel DiscussionsПодробнее

Case Based Panel Discussion - EGFR Mutation -The Recommended Treatment for Common EGFR MutationsПодробнее

Case Based Panel Discussions - EGFR Mutation and FLAURA Trial - Demographics, Effect on Treatment?Подробнее

Case Based Panel Discussion - EGFR and High PDL1 What is the Role of Immunotherapy in Treatment?Подробнее

Case Based Panel Discussion - EGFR and High PDL-1, Choosing Targeted Therapy or ImmunotherapyПодробнее

Case Based Panel Discussions - EGFR Mutation & MET - Treatment Decisions, Level of MET AmplificationПодробнее

EGFR Mutated Adenocarcinoma - Case Based Panel DiscussionsПодробнее

Case Based Panel Discussion - EGFR: Oligoprogression Brain &/or Body vs. Worsening ProgressionПодробнее

DEBATE: Drug of choice for exon 19 del EGFR mutant NSCLC - AfatinibПодробнее

Panel Discussion: Advances in Lung Cancer Treatment | CRSF 2023 ReviewПодробнее

Case Based Panel Discussion - EGFR Mutation Treated with Tagrisso Progression While on Treatment, anПодробнее

Case Based Panel Discussion - Adv Non Squamous NSCLC, Low PD-L1 No Mutation - Best Systemic Therapy?Подробнее

Case Based Panel Discussion 3.1 EGFR Mutation - Chemotherapy and an EGFR Inhibitor Concurrently or SПодробнее

Panel Discussion: Combination Therapy in Advanced EGFRm NSCLC | CRSF 2023 ReviewПодробнее

Exon 20 Mutation: Unveiling the Hidden Threat in EGFR NSCLC | CRSFПодробнее

Case Based Panel Discussion - EGFR Mutation with MET Amplification Treatment Decisions and the ImporПодробнее

Case Based Panel Discussion - EGFR - Exon 20 Mutation, Treatment, Targeted Therapy, Clinical TrialsПодробнее

Patient and Caregiver Panel | 2024 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее